Regulatory agencies, including the FDA and EMA, closely monitor Semaglutide
Theres significant bipartisan support for the bill, and many of us in the field of obesity medicine are hopeful that Medicare and Medicaid will begin covering GLP-1s for weight loss. Dr
Current law blocks Medicare weight-loss drug coverage Policy changes expected mid-2026 Medicaid coverage remains state-dependent What This Means for You Check your specific plan: Self-funded employers can still choose to cover Zepbound During open enrollment: Ask HR about 2026 GLP-1 coverage changes Consider alternatives: Wegovy is covered on most Aetna plans with similar efficacy Self-pay options: TrumpRx ($346/month), LillyDirect ($299-$449/month), or Foundayo (~$149/month oral GLP-1)
While some patients report vasomotor symptoms during treatment, there is no established pharmacological mechanism directly linking tirzepatide to hot flashes
What is the immunogenicity concern
Wegovy pill mechanism of action The Wegovy pill uses semaglutide, the same active ingredient as Wegovy injections and Ozempic, paired with a compound called SNAC (sodium N-[8-(2-hydroxybenzoyl) aminocaprylate]) that helps the peptide survive stomach acid